Souhaitez-vous accéder aux communiqués récents ?

OESX: ORION ENERGY SYSTEMS, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)

VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (TSX:III) (the “Company” or “Imperial”) announces that, further to the Company’s news release dated May 9,...

                                                                Charenton-le-Pont, 26 June 2025 DESCRIPTION OF THE SHARE BUYBACK PROGRAMME AUTHORISED BY THE ORDINARY GENERAL MEETING OF 26 JUNE 2025 ...

Los Angeles, June 26, 2025 (GLOBE NEWSWIRE) -- Proto Inc., the original holographic communications and AI spatial computing platform, has officially been awarded the trademark for the phrase “Beam...

SHANGHAI, China, June 26, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data...

Hod Hasharon, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Allot Ltd. (Nasdaq: ALLT; TASE: ALLT) (“Allot” or the “Company”), a leading global provider of innovative network intelligence and security...

Dallas, TX, June 24, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today...

Hod Hasharon, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Allot Ltd. (Nasdaq: ALLT; TASE: ALLT) (“Allot” or the “Company”), a leading global provider of innovative network intelligence and security...

--During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study;...

Independent DSMB identifies no safety concerns, and recommends continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor Review marks third consecutive positive...